Straumann Holding has seen its share price move around over the years. The question today is whether the current Swiss franc 98.88 level is properly backed by the cash the business can generate. For anyone looking at Straumann Holding stock now, the key issue is how that price lines up against an intrinsic value estimate built from its cash flows.
-
The share price has declined 46.0% over the past 5 years. This puts the focus squarely on whether the long term cash flow profile still supports a valuation near today's level.
-
The group relies heavily on converting dental implant demand into consistent free cash generation. As a result, assumptions about procedure volumes, pricing power and reinvestment needs can materially shift any intrinsic value estimate built from its cash flows.
-
If you'd rather focus on earnings, this one's for you. See why Straumann Holding's 42.7x P/E tells a different valuation story .
The issue now is whether Straumann Holding's current market price is justified by the cash flows implied in its Discounted Cash Flow (DCF) intrinsic value estimate.
If you are weighing Straumann Holding against other opportunities that also hinge on cash generation, it can help to compare its profile with 193 high quality undervalued stocks
Is Straumann Holding Still Cheap on Cash Flow?
The Discounted Cash Flow (DCF) model here looks at what Straumann Holding can return to shareholders based on future free cash generation. Latest twelve month free cash flow sits around CHF327.3 million, so this is not a story of a business that needs to reach profitability first. Analysts and modelled estimates point to growing free cash flow in the coming decade, with 2030 projections materially higher than today in absolute CHF terms.
Those assumptions lean on Straumann Holding turning steady demand for dental implants into rising cash available to equity holders, while still funding its own reinvestment. Based on these cash flow projections, the DCF suggests an intrinsic value that comes out substantially above the current CHF98.88 share price. This indicates that the market is pricing Straumann more cautiously than the cash flow model implies. Find out what Straumann Holding could be worth using our Discounted Cash Flow (DCF) estimate .
The Straumann Holding Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for Straumann Holding pick up where the DCF puzzle leaves off and explain which paths for growth, margins and earnings would need to occur for the stock to appear materially stronger or weaker than today's price. Each scenario links its valuation figure to a clear view on how Straumann Holding's growth profile, profitability and risks could change, providing a reference point you can revisit as new information becomes available.
Community views on Straumann Holding are split between those who see more upside in its digital push and those who worry about margin execution and tariffs.
Bull case: 13% undervalued
"Continued double digit growth in Straumann Holding digital solutions such as SIRIOS X3 scanners and expanding AXS cloud adoption points to a larger installed base…"
Discover why this Narrative puts Straumann Holding at 13% undervalued .
Bear case: 12% overvalued
"Although Straumann Holding highlights strong momentum in digital solutions and intraoral scanners, the recent earnings miss driven by margin compression shows that converting a growing scanner and AXS user base into consistent, high quality earnings is not yet proven…"
Explore why this Narrative puts Straumann Holding at 12% overvalued .
Straumann Holding: one more piece of the puzzle worth checking
Cash flows tell only part of the Straumann Holding story, because the people setting priorities and how they are rewarded can tilt long term outcomes in very different directions. See who runs Straumann Holding and how they are paid .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include STMN.SW .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
